# Proof of Principle Trial to Determine if Nutritional Supplement Conjugated Linoleic Acid (CLA) Can Modulate the Lipogenic Pathway in Breast Cancer Tissue

> **NCT00908791** · EARLY_PHASE1 · COMPLETED · sponsor: **Dartmouth-Hitchcock Medical Center** · enrollment: 24 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Conjugated Linoleic Acid (CLA)

## Key facts

- **NCT ID:** NCT00908791
- **Lead sponsor:** Dartmouth-Hitchcock Medical Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2019-04-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00908791

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00908791, "Proof of Principle Trial to Determine if Nutritional Supplement Conjugated Linoleic Acid (CLA) Can Modulate the Lipogenic Pathway in Breast Cancer Tissue". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00908791. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*